Fatty liver
Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials
... criteria, representing 6826 subjects. In overweight but not obese subjects, probiotics induced improvements in: body weight (k=25 trials, d=−0.94 kg mean difference, 95% CI −1.17 to −0.70, I²=0.0%), body mass index ...
13
Endoplasmic Reticulum stress signaling and the pathogenesis of Non-Alcoholic Fatty Liver Disease
... affects liver function. Non-alcoholic fatty liver disease (NAFLD) is the most common etiology of chronic liver disease affecting 25% of the general population worldwide(1) and 85-98% of ...
56
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study
... * terencendonyi.bukong@iaf.inrs.ca Abstract Cannabis use is associated with reduced prevalence of obesity and diabetes mellitus (DM) in humans and mouse disease models. Obesity and DM are a well-established independent ...
17
Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
... dysfunction-associated fatty liver disease (MAFLD, the term now replacing nonalcoholic fatty liver disease or NAFLD), which is present in the majority of obese people, was also found to be ...
32
Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.
... These fatty liver indexes are simple clinical tools for evaluating the extent of liver fat and they are predictive of incident ...with fatty liver. Background Non-alcoholic fatty ...
10
en fr Progression and diagnostic methods in non-alcoholic fatty liver disease Progression et tests diagnostiques de la stéatose hépatique non alcoolique
... against liver biopsy, neither compared head-to-head in a single ...The Fatty Liver Index has been developed in a cohort of patients from the general population with ultrasound- diagnosed hepatic ...
181
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
... Food insecurity is associated with obesity, diabetes, and hypertension and drives a cardiometabolic risk pro file, which are all risk factors for fatty liver development. 33 Conse- quently, policies to ...
8
Genetic parameters along the near infra red spectra to predict melting rate of the duck fatty liver
... Genetic parameters along the near infra red spectra to predict melting rate of the duck fatty liver C. Marie-Etancelin 1* , Z.G. Vitezica 2 , L. Bonnal 3 and D. Bastianelli 3 1 INRA UR631, SAGA, BP 52627, ...
2
Identifying PGC-1α-dependent hepatokines in a non-alcoholic fatty liver disease murine model
... Non-alcoholic fatty liver disease (NAFLD) has become a serious public health problem and is now considered as the major cause of liver disease ...of liver diseases starting with non-alcoholic ...
82
Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
... that fatty liver does not affect renal function and CKD development can be induced only by an alteration of intra-renal metabolism and without hepatic steatosis, whereas many recent studies suggested a ...
17
Nonalcoholic fatty liver disease and obstructive sleep apnea
... nonalcoholic fatty liver disease ...exacerbating liver oxidative stress. OSA also disrupts the gut liver axis, increasing intestinal permeability and with a possible role of gut microbiota in ...
28
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes
... (C) Similar calculations were made for the DIACART cohort (n = 149), but, for ceramide and sphingomyelin, only the sum of the different species is presented. (B and D) Positive correlations are depicted in red and ...
17
Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome
... measures, liver histology, hepatic lipid measurements and liver genome-wide gene transcription profiling in C57BL/6J and BALB/c mice fed either a control or a high fat ...alcoholic fatty liver ...
13
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
... organoids; liver-on-a-chip; cell culture 1. Introduction Non-alcoholic fatty liver disease (NAFLD) comprises two histological forms: non- alcoholic fatty liver (NAFL) and non-alcoholic ...
19
AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
... and fatty liver disease ( Smith et ...the liver ( Foretz et ...on fatty acid synthesis during the conversion of acetate into fatty acids ( Beynen et ...inhibit fatty acid ...
17
Specificities of Human Hepatocellular Carcinoma Developed on Non-Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue Extracts 1H-NMR Spectroscopy
... non-alcoholic fatty liver disease (NAFLD) as well as of the frequency of Hepato-Cellular Carcinoma (HCC) associated with ...normal liver (n = 6) and NAFLD (n = ...
18
Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment
... Non-alcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 ...regulating liver micro- and macrovesicular steatosis and inflammation, independently from glucose intolerance ...
11
Specificities of Hepatocellular Carcinoma Developed on Non Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue 1H-NMR Spectroscopy
... Alcoholic Fatty Liver Disease (NAFLD) occurs in 40% of cases in the absence of cirrhosis and therefore may escape detection enabled by systematic screening of cirrhotic patients ...
2
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
... 2019;9:5688. 89. Anon. Clinical study of probiotics in treatment of non-alcoholic fatty liver disease-- 《Chinese Journal of Gastroenterology and Hepatology》2013年年03期. Available at: ...
38
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
... in liver of Ppar β / δ -null mice and in Ppar β / δ - knocked down mouse primary hepatocytes through mechanisms involving the heme-regulated eukaryotic translation initiation factor 2 α (eIF2 α) kinase (HRI), ...
40